Antares Pharma, Inc. (ATRS)

[scubastevo80]

My notes on the conf call...

Otrexup - 3 district managers, 25 reps hired by Thanksgiving
- 3rd party players involved, talked w/ Top 30
- will be covered by 29, UHC won't cover Tier 3 for 6 months
- 20-25 speakers to advocate in US/Europe for Otrexup
- 3 new Otrexup patents, about 20 total good through 2030
- pricing strategy = $548 (1mo supply, 4units, 1 dose/week)
- discussions w/ payers covering 200M lives, copay at launch, value increase will eventually move to Tier 2
- Psoriasis commericalization will be done with a partner

QST - fully enrolled ahead of schedule
- complete results available Q1 2014, target launch 2016

Pipeline - PFE OTC program on track, looking for 2016 launch
(believe I heard an analyst try to ask about the Advil Gel program, then she dropped)
- EpiPen making good progress w/ Teva, 6/20/15 commercialization
- SGA expense will be 2c/share starting in 2014 due to Oxtrexup